Cargando…
Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies
Large-scale compound screens are a powerful model system for understanding variability of treatment response and discovering druggable tumor vulnerabilities of hematological malignancies. However, as mostly performed in a monoculture of tumor cells, these assays disregard modulatory effects of the i...
Autores principales: | Herbst, Sophie A., Kim, Vladislav, Roider, Tobias, Schitter, Eva C., Bruch, Peter-Martin, Liebers, Nora, Kolb, Carolin, Knoll, Mareike, Lu, Junyan, Dreger, Peter, Müller-Tidow, Carsten, Zenz, Thorsten, Huber, Wolfgang, Dietrich, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558604/ https://www.ncbi.nlm.nih.gov/pubmed/37352275 http://dx.doi.org/10.1182/bloodadvances.2022009652 |
Ejemplares similares
-
SBNO2 is a critical mediator of STAT3-driven hematological malignancies
por: Brandstoetter, Tania, et al.
Publicado: (2023) -
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies
por: Thomalla, D., et al.
Publicado: (2022) -
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics
por: Hamadani, Mehdi, et al.
Publicado: (2022) -
Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma
por: Bolomsky, Arnold, et al.
Publicado: (2021) -
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
por: Baech, Joachim, et al.
Publicado: (2022)